Randomised, open-label, active-controlled, multicentre, comparative study to evaluate the safety and efficacy of ferric maltol (iron(III)-maltol complex) (ST10) oral suspension compared to ferrous sulfate oral liquid in children and adolescents aged 2 to 17 years with iron-deficiency anaemia, incorporating a single arm study in infants aged 1 month to less than 2 years - FORTIS

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2025
This article has no abstract
Epistemonikos ID: 3cb8ced2d39cdafb00416555d8f42820e6cb09df
First added on: Apr 09, 2025